am 580 and ro 41-5253

am 580 has been researched along with ro 41-5253 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, SJ; Dawson, MI; Jetten, AM; Mills, KJ; Zhang, LX1
Eckhardt, K; Schmitt, G1
Brooks, SC; Kazmer, S; Levin, AA; Yen, A1
Dawson, MI; Klaus, M; López-Boado, YS; López-Otín, C1
Commes, T; Defacque, H; Marti, J; Piquemal, D; Rochette-Egly, C; Sévilla, C1
Li, Y; MacLennan, AJ; Rogers, MB1
Billin, AN; Curtin, JC; Kim, RJ; Lazar, MA; Schupp, M1
Collins, G; Dawson, HD; Key, M; Pyle, R; Taub, DD1

Other Studies

8 other study(ies) available for am 580 and ro 41-5253

ArticleYear
Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids.
    The Journal of biological chemistry, 1995, Mar-17, Volume: 270, Issue:11

    Topics: Animals; Apoptosis; Benzoates; Bronchi; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Chromans; Chromatin; Enzyme Induction; Epithelium; Gene Expression; Humans; Luciferases; Lung Neoplasms; Rats; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Retinoids; Signal Transduction; Tetrahydronaphthalenes; Trachea; Transcription Factors; Transfection; Transglutaminases; Tumor Cells, Cultured

1995
A retinoic acid receptor alpha antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo.
    Toxicology letters, 1994, Feb-15, Volume: 70, Issue:3

    Topics: Abnormalities, Drug-Induced; Animals; Benzoates; Cell Differentiation; Cells, Cultured; Chromans; Cleft Palate; Ear, External; Extremities; Female; Mice; Pregnancy; Rats; Receptors, Retinoic Acid; Retinoids; Tetrahydronaphthalenes

1994
Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs.
    Blood, 1996, Jan-01, Volume: 87, Issue:1

    Topics: Benzoates; Cell Differentiation; Chromans; Cyclohexanes; Fatty Acids, Unsaturated; Flow Cytometry; HL-60 Cells; Humans; Ligands; Neoplasm Proteins; Pentanoic Acids; Phosphorylation; Protein Processing, Post-Translational; Receptors, Retinoic Acid; Retinoblastoma Protein; Retinoid X Receptors; Retinoids; Structure-Activity Relationship; Substrate Specificity; Tetrahydronaphthalenes; Transcription Factors; Tretinoin

1996
Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway.
    The Journal of biological chemistry, 1996, Dec-13, Volume: 271, Issue:50

    Topics: Antineoplastic Agents; Apolipoproteins; Apolipoproteins D; Benzoates; Breast Neoplasms; Cell Division; Chromans; Female; Humans; Morpholines; Receptors, Retinoic Acid; Retinoids; RNA, Messenger; Signal Transduction; Tetrahydronaphthalenes; Tretinoin

1996
Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Leukemia, 1997, Volume: 11, Issue:2

    Topics: Alitretinoin; Animals; Benzoates; Bexarotene; Cell Differentiation; Chromans; COS Cells; HL-60 Cells; Humans; Leukemia, Monocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Molecular Structure; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; Retinoids; Signal Transduction; Tetrahydronaphthalenes; Transcription Factors; Transfection; Tretinoin; Tumor Cells, Cultured; Vitamin D

1997
A putative G-protein-coupled receptor, H218, is down-regulated during the retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
    Experimental cell research, 1998, Mar-15, Volume: 239, Issue:2

    Topics: Animals; Benzoates; Bucladesine; Carcinoma, Embryonal; Cell Differentiation; Chromans; Down-Regulation; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Mice; Naphthalenes; Neoplasm Proteins; Phenotype; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Receptors, Retinoic Acid; Retinoids; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tetrahydronaphthalenes; Tretinoin; Tumor Cells, Cultured

1998
A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
    Molecular pharmacology, 2007, Volume: 71, Issue:5

    Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Benzoates; Cell Line; Chromans; Down-Regulation; Fatty Acid-Binding Proteins; Gene Expression; Humans; Inhibitory Concentration 50; Mice; PPAR delta; PPAR gamma; PPAR-beta; Protein Isoforms; Protein Structure, Tertiary; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Tetrahydronaphthalenes

2007
The Retinoic Acid Receptor-alpha mediates human T-cell activation and Th2 cytokine and chemokine production.
    BMC immunology, 2008, Apr-16, Volume: 9

    Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Benzoates; Cell Differentiation; Chromans; Cytokines; Dermatologic Agents; Fenretinide; Gene Expression Regulation; Humans; Lectins, C-Type; Lymphocyte Activation; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Tetrahydronaphthalenes; Th2 Cells; Tretinoin; Tumor Cells, Cultured

2008